Advising Healthtech Platform on investor share transfer
Collyer Law LLC advised Docquity, Southeast Asia’s largest social media business for healthcare professionals, on the transfer of shares...
Nov 30, 20241 min read
Advised a biotechnology unicorn on an aborted acquisition valued at US$ 35 million
Collyer Law advised an American Biotechnology unicorn, specializing in gene therapy, on an aborted acquisition of a Singapore-Based...
Jan 15, 20241 min read
Advising Allozymes on commercial contracts
Collyer Law LLC advised Allozymes Pte. Ltd., a leading biotechnology company leveraging proprietary microfluidics technology for the...
Nov 1, 20231 min read
Advised Allozymes on commercial lease
Collyer Law advised Allozymes Pte Ltd, a leading deep technology company that applies its proprietary microfluidics technology to develop...
Jul 11, 20231 min read
Advising Docquity Holdings on US$44M Series C round
Collyer Law advised Docquity Holdings Pte. Ltd., a medical technology platform with Southeast Asia’s largest community of healthcare...
Sep 7, 20221 min read
